Director – Oncology New Product Planning – Early Stage Assets

Director – Oncology New Product Planning – Early Stage Assets

Requirements

• Bachelor’s degree in a related field (e.g., business, chemistry, biology); Advanced Degree (MBA, PhD, PharmD) preferred
• 10+ years pharmaceutical industry experience, oncology experience required
• At least 7 years in commercial roles (brand marketing, sales, market research/analytics, new product planning, managed markets); global experience preferred
• Significant commercial experience required in new product planning, early stage assets
• Experience defining disease area strategies or corporate strategy experience required
• Deep understanding of pharmaceutical R&D process required; prefer prior experience working with development teams
• Significant experience leading cross-functional teams, including senior leaders, to accomplish shared goals
• Demonstrated exceptional strategic thinking ability
• Demonstrated ability to understand and translate clinical/scientific information
• This position requires ~ 10% travel, including international trips.

Responsibilities

• Represent the Oncology Business Unit (OBU) as early stage asset lead on early pipeline Global Program Teams (GPTs) and contribute the global commercial perspective to clinical development decisions within the GPT (including Clinical, GMA, Project Management, and Regulatory) on key factors such as indications, endpoints, populations and trial comparator to ensure through analysis and understanding of the necessary clinical and regulatory threshold to ensure successful commercialization, market differentiation, and alignment with DASs.
• Co-lead GPT in identifying, developing and championing asset maximization strategies, and facilitate GPT decision-making through the communication of clear and unified global commercial strategy to optimize overall market value of each asset
• Develop early brand plans/early product opportunity profiles for early stage assets with global cross-functional input (Patient value and Access, Medical Affairs, HEOR, Competitive Intelligence), including a global commercial assessment of the market and asset opportunity that is used to facilitate clinical development planning, brand strategy development, patient insights, value proposition, financial valuation, and tactical planning/budgeting
• Conduct market analyses to shape optimized target product profiles, product positioning, and target product claims
• Lead all regional pipeline communication and activities for early stage assets
• Advise on commercial assessments of potential BD and M&A opportunities, as needed, and as liaison with iDAS business leads
• Provide forecasts for early stage assets and the potential for the franchise
• Stay abreast of oncology treatment landscape and key competitors in order to adapt early commercial strategies accordingly to ensure success of these early stage assets
• This position is responsible for leading pipeline commercial strategy for early commercial assets and liaising with the iDAS to ensure alignment of asset strategy and the iDAS strategies. As part of this charge, the Director, NPP- Early Stage Assets works globally and cross-functionally (Regional Marketing, Market Research, Business Intelligence, BD, Alliance Management, Patient Value and Access, Medical Affairs etc.), to develop strategies that will provide the greatest returns to Takeda. The Director, NPP – Early Stage Assets delivers strategies, forecasts and commercial plans, aligned to the overall disease area strategy, for endorsement by Head of NPP, Oncology Leadership Team, Takeda Oncology Management Meeting (TOMM), Oncology Development Steering Team (ODeST) and Portfolio Review Committee (PRC).

Preferred Qualifications

• Advanced Degree (MBA, PhD, PharmD) preferred
• Global experience preferred
• Prefer prior experience working with development teams
• Prefer prior experience working in oncology